How is the Genelux Corp today?

The Genelux Corp today is trading in the down by -9.45% at 2.49.

What is Genelux Corp Annual Revenue?

Genelux Corp Annual Revenue fell 95.29%, in the last year to $0.01 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Genelux Corp Annual Net Profit?

Genelux Corp Annual Net Profit fell 5.56% in the last year to $29.87 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is Genelux Corp Price to Earning Ratio?

Genelux Corp Price to Earning Ratio is -3.18, which is negative.

What is Genelux Corp Stock Price?

Genelux Corp Stock Price fell 42.09% and underperformed its sector by 53.42% in the past year.

What is Genelux Corp Quarterly Net profit?

Genelux Corp Quarterly Net profit rose 4.56% YoY to $7.49 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is Genelux Corp Debt to Equity Ratio?

Genelux Corp Debt to Equity Ratio of 0.07 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Genelux Corp Return on Equity(ROE)?

Genelux Corp Return on Equity(ROE) for the last financial year was -130.58%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Genelux Corp Mutual Fund Holding?

Genelux Corp Mutual Fund Holding decreased by 0.08% in the last quarter to 7.26.

What is Genelux Corp Institutional Holding?

Genelux Corp Institutional Holding increased by 3.52% in the last quarter to 16.98.

Genelux Corp XNAS: GNLX

Genelux Corp Live Share Price Today, Share Analysis and Chart

Name: Genelux Corp: Is Infosys Ltd. worth buying?
Item: Genelux Corp
Rating: 1.10191675
Author: Trendlyne DVM scores

about

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products includ...

2.49 -0.26 (-9.45%)

57.65% Fall from 52W High

112.1K XNAS Volume

XNAS 21 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

5.2 / 100

Technically Neutral

38.9 / 100

18

1Yr Price target upside is 607%

5 analysts

Genelux Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Genelux Corp FAQ

How is Genelux Corp today?

Genelux Corp today is trading in the red, and is down by -9.45% at 2.49.

How has Genelux Corp performed historically?

Genelux Corp is currently trading down -9.45% on an intraday basis. In the past week the stock rose 0.40%. stock has been down -48.34% in the past quarter and fell -42.09% in the past year. You can view this in the overview section.